ACCESS TO MEDICINES /
OUR WORK IN SPAIN
WHAT IS HAPPENING WITH ACCESS TO MEDICINES?
The lack of access to treatments for Hepatitis C has been the most notorious example of the growing problem that exists with the exorbitant price of drugs and with the monopolies that patents on medicines facilitate to pharmaceutical companies.
Through an open debate co-organized with the Official College of Physicians and the Collegial Medical Organization, and including panelists in the field of access to medicines, we wanted to make it known to the public that changes in innovation and science are necessary and that steps are being taken in that direction.
Through an open debate co-organized with the Official College of Physicians and the Collegial Medical Organization, and including panelists in the field of access to medicines, we wanted to make it known to the public that changes in innovation and science are necessary and that steps are being taken in that direction.